These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7198986)

  • 81. [Evaluation of the agreement between cytological and histological examinations in the diagnosis of cervical cancer].
    Kujawska E; Waszyński E
    Wiad Lek; 1981 Aug; 34(15):1263-6. PubMed ID: 7331327
    [No Abstract]   [Full Text] [Related]  

  • 82. [Toilet of the portio: a reliable technic for the diagnosis and treatment of cervical lesions].
    Blanda A; Gambaro C
    Minerva Ginecol; 1987 Oct; 39(10):723-6. PubMed ID: 3431740
    [No Abstract]   [Full Text] [Related]  

  • 83. [Indirect metaplasia and carcinoma of the cervical mucosa in pregnancy].
    Link M
    Zentralbl Gynakol; 1974 Feb; 96(6):161-72. PubMed ID: 4825923
    [No Abstract]   [Full Text] [Related]  

  • 84. [Electronic analysis of colposcopic and cytologic findings in carcinoma in situ].
    Szalmay G; Roemer VM; Jochum L
    Arch Gynakol; 1975 Nov; 219(1-4):68-9. PubMed ID: 1243514
    [No Abstract]   [Full Text] [Related]  

  • 85. Adenocarcinoma-in-situ of the cervix uteri associated with cervical intraepithelial neoplasia in pregnancy. Case report.
    Drew NC
    Br J Obstet Gynaecol; 1984 May; 91(5):498-502. PubMed ID: 6722066
    [No Abstract]   [Full Text] [Related]  

  • 86. First results of routine cytologic diagnosis of uterine cervical carcinoma in one clinic in Israel. Four case reports.
    Levy E; Barkay J
    Acta Cytol; 1972; 16(6):523-6. PubMed ID: 4509286
    [No Abstract]   [Full Text] [Related]  

  • 87. Aspects of statistics in studies of cell proliferation. II. Standard errors of estimated parameters.
    Appleton DR
    Cell Tissue Kinet; 1984 Nov; 17(6):657-9. PubMed ID: 6488282
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Inactivation of human cells cultivated in vitro by the new mitotic inhibitors NY 4137 and NY 4138.
    Nygaard ME; Pettersen EO; Dornish JM; Undheim K; Oftebro R
    Invest New Drugs; 1987; 5(3):259-66. PubMed ID: 3667161
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Mitotic arrest and interphase inhibition induced by the pyrimidine sulfoxide NY 4138.
    Pettersen EO; Nome O; Dornish JM; Oftebro R
    Invest New Drugs; 1985; 3(3):245-53. PubMed ID: 4066219
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Synergistic cell inactivation by cis-dichlorodiammineplatinum in combination with 1-propargyl-5-chloropyrimidin-2-one.
    Dornish JM; Pettersen EO; Oftebro R
    Br J Cancer; 1987 Sep; 56(3):273-8. PubMed ID: 3663475
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Multicellular spheroids. A review on cellular aggregates in cancer research.
    Mueller-Klieser W
    J Cancer Res Clin Oncol; 1987; 113(2):101-22. PubMed ID: 3549738
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Postconfluency MDCK monolayers as an in vitro model of solid tumor chemosensitivity.
    Skehan P; Thomas J; Friedman SJ
    Cell Biol Toxicol; 1986 Sep; 2(3):357-68. PubMed ID: 3267455
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Use of a tritiated thymidine suicide technique in the study of the cytotoxic drug response of cells located at different depths within multicellular spheroids.
    Kwok TT; Twentyman PR
    Br J Cancer; 1987 Apr; 55(4):367-74. PubMed ID: 3034319
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The VM model of glioma: preparation of multicellular tumour spheroids (MTS) and their response to chemotherapy.
    Bradford R; Darling JL; Sier N; Thomas DG
    J Neurooncol; 1990 Oct; 9(2):105-14. PubMed ID: 2262797
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A study of factors related to the action of 1-propargyl-5-chloropyrimidin-2-one (NY 3170) and vincristine in human multicellular spheroids.
    Wibe E; Oftebro R
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1053-9. PubMed ID: 7198986
    [No Abstract]   [Full Text] [Related]  

  • 96. Age-dependent cell inactivation by vincristine alone or in combination with 1-propargyl-5-chloropyrimidin-2-one.
    Wibe E
    Cancer Res; 1980 Jun; 40(6):2069-73. PubMed ID: 7371040
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Resistance to vincristine of human cells grown as multicellular spheroids.
    Wibe E
    Br J Cancer; 1980 Dec; 42(6):937-41. PubMed ID: 7459228
    [No Abstract]   [Full Text] [Related]  

  • 98. Inhibitory effects of the new mitotic inhibitor 5-chloropyrimidin-2-one and of vincristine on human cells in vitro.
    Wibe E; Oftebro R; Christensen T; Laland SG; Pettersen EO; Lindmo T
    Cancer Res; 1978 Mar; 38(3):560-5. PubMed ID: 626961
    [No Abstract]   [Full Text] [Related]  

  • 99. [Present status of conization in the diagnosis and treatment of cervical intraepithelial neoplasia].
    Lohe KJ; Kürzl R; Baltzer J
    Gynakologe; 1981 Dec; 14(4):233-8. PubMed ID: 7033081
    [No Abstract]   [Full Text] [Related]  

  • 100. Underwriting implications of carcinoma in situ of the cervix.
    Vecchione L
    J Insur Med; 1998; 30(4):226-30. PubMed ID: 10537927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.